# Longevity for Women

Women live about five years longer than men, but they spend more of those years in poor health. So the real goal is closing that healthspan gap. The turning point is menopause, when estradiol drops roughly 90% and bone loss, heart risk, and cognitive risk all speed up. Three moves do the heavy lifting: strength training 2 to 4 times a week, at least 1.2 g protein per kg of body weight, and a baseline blood panel (thyroid, ferritin, lipids with Lp(a), vitamin D) plus an honest HRT conversation with a menopause-literate doctor.

How women actually age, what hormones do to a long life, and the science-backed moves for your bones, heart, brain, and muscle

## On this page

- Why Is Women's Longevity Different?
- How Do Hormones Drive Female Aging?
- How Do Women Protect Bone and Muscle?
- What Makes Women's Heart Risk Unique?
- Why Are Women More Affected by Alzheimer's?
- What Should Women Eat for Longevity?
- Which Exercise Matters Most for Women's Healthspan?
- Where Do You Start?
- How Do You Find a Menopause-Literate Physician in DACH?
- What Does DACH HRT Actually Look Like (Formulations, Costs, Prescribing)?
- What Should Your Age-40 Screening Panel Cover?
- Which Symptom Means Which Next Step?
- How Do You Hit Protein and Bone Targets in a DACH Kitchen?
- Do GLP-1s Interact With HRT?

## FAQ

- Do women age differently than men?
- Should women take HRT for longevity?
- What is the best exercise for women over 40?
- How does menopause affect aging?
- What supplements should women take for longevity?

## Sources

- Manson JE, Aragaki AK, Rossouw JE, et al.. (2017). Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: WHI Randomized Trials. JAMA. https://doi.org/10.1001/jama.2017.11217
- Greendale GA, Sowers M, Han W, et al.. (2012). Bone mineral density loss across the menopausal transition (SWAN). Journal of Bone and Mineral Research. https://doi.org/10.1002/jbmr.534
- Wu P, Haththotuwa R, Kwok CS, et al.. (2017). Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis. Circulation: Cardiovascular Quality and Outcomes. https://doi.org/10.1161/CIRCOUTCOMES.116.003497
- Inversetti A, Pivato CA, Cristodoro M, et al.. (2024). Update on long-term cardiovascular risk after pre-eclampsia: a systematic review and meta-analysis. European Heart Journal - Quality of Care and Clinical Outcomes. https://doi.org/10.1093/ehjqcco/qcad065
- NAMS Hormone Therapy Position Statement Advisory Panel. (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. https://doi.org/10.1097/GME.0000000000002028
- Kraus WE, Bhapkar M, Huffman KM, et al.. (2019). 2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/S2213-8587(19)30151-2
- Rossouw JE, Anderson GL, Prentice RL, et al.. (2002). Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: WHI. JAMA. https://doi.org/10.1001/jama.288.3.321
- Hodis HN, Mack WJ, Henderson VW, et al.. (2016). Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol (ELITE). New England Journal of Medicine. https://doi.org/10.1056/NEJMoa1505241
- Panay N, Ang SB, Cheshire R, Goldstein SR, Maki P, Nappi RE. (2024). Menopause and MHT in 2024: addressing the key controversies — an International Menopause Society White Paper (Climacteric 2024;27(5):441-457, PMID 39268862). Climacteric. https://doi.org/10.1080/13697137.2024.2394950

_Full guide: https://longevity-austria.com/en/guide/longevity-for-women_

---

_Canonical: https://longevity-austria.com/en/guide/longevity-for-women · Part of Longevity Cities · Updated 2026-05-22_